相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
J. Schmitt et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis
J. M. P. A. van den Reek et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Survival rate of antitumour necrosis factor- treatments for psoriasis in routine dermatological practice: a multicentre observational study
M. Esposito et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre
A. Lopez-Ferrer et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Long-term safety of ustekinumab for psoriasis
Neal Kumar et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Drug survival rates in patients with psoriasis after treatment with biologics
Yoshinori Umezawa et al.
JOURNAL OF DERMATOLOGY (2013)
Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologic-naive vs. non-naive patients
P. P. M. van Lumig et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
A. B. Kimball et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Drug survival rates of biologic treatments in patients with psoriasis vulgaris
A. M. G. Brunasso et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
S3-Guidelines on the treatment of psoriasis vulgaris (English version). Update
Alexander Nast et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2012)
Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: Long-term results from a phase 2/3 clinical trial
Atsuyuki Igarashi et al.
JOURNAL OF DERMATOLOGY (2012)
Dermatology Life Quality Index (DLQI): A Paradigm Shift to Patient-Centered Outcomes
Andrew Y. Finlay et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis
David M. Pariser et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis A Comprehensive Analysis of All Adalimumab Exposure in All Clinical Trials
Craig Leonardi et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)
Treatment Response, Drug Survival, and Predictors Thereof in 764 Patients With Psoriatic Arthritis Treated With Anti-Tumor Necrosis Factor α Therapy Results From the Nationwide Danish DANBIO Registry
Bente Glintborg et al.
ARTHRITIS AND RHEUMATISM (2011)
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
R. Gniadecki et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)
Tsen-Fang Tsai et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Responses to ustekinumab in the anti-TNF agent-naive vs. anti-TNF agent-exposed patients with psoriasis vulgaris
A. Clemmensen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE
J. -P. Ortonne et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab
Jacqueline M. Benson et al.
NATURE BIOTECHNOLOGY (2011)
Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
Akihiko Asahina et al.
JOURNAL OF DERMATOLOGY (2010)
Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept
Robert Bissonnette et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Transmembrane TNF-α: structure, function and interaction with anti-TNF agents
Takahiko Horiuchi et al.
RHEUMATOLOGY (2010)
Adalimumab treats psoriasis in patients previously treated with etanercept: A case series
Paul S. Yamauchi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Adalimumab for psoriasis patients who are non-responders to etanercept: open-label prospective evaluation
C. L. Martyn-Simmons et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Sustained efficacy and safety of adalimumab in psoriasis treatment: A retrospective study of 49 patients with and without a history of TNF-alpha antagonist treatment
Livia Van et al.
ARCHIVES OF DERMATOLOGY (2008)
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics
Marina Papoutsaki et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis
Angela Moore et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis
Stephen Tyring et al.
ARCHIVES OF DERMATOLOGY (2007)
Clinical response to alimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study
Kenneth B. Gordon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Translating the science of quality of life into practice: What do dermatology life quality index scores mean?
Y Hongbo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
分享论文
